Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Current Assets (2022 - 2025)

Historic Current Assets for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $49.8 million.

  • Lucid Diagnostics' Current Assets rose 19625.53% to $49.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.8 million, marking a year-over-year increase of 19625.53%. This contributed to the annual value of $25.1 million for FY2024, which is 1393.1% up from last year.
  • According to the latest figures from Q3 2025, Lucid Diagnostics' Current Assets is $49.8 million, which was up 19625.53% from $33.8 million recorded in Q2 2025.
  • Over the past 5 years, Lucid Diagnostics' Current Assets peaked at $52.3 million during Q1 2022, and registered a low of $16.8 million during Q3 2024.
  • Over the past 4 years, Lucid Diagnostics' median Current Assets value was $27.9 million (recorded in 2024), while the average stood at $31.9 million.
  • Its Current Assets has fluctuated over the past 5 years, first tumbled by 3838.04% in 2024, then skyrocketed by 19625.53% in 2025.
  • Over the past 4 years, Lucid Diagnostics' Current Assets (Quarter) stood at $24.4 million in 2022, then dropped by 9.37% to $22.1 million in 2023, then increased by 13.93% to $25.1 million in 2024, then surged by 98.19% to $49.8 million in 2025.
  • Its Current Assets stands at $49.8 million for Q3 2025, versus $33.8 million for Q2 2025 and $27.5 million for Q1 2025.